We establish a specific small interfering RNA (siRNA) to inhibit CAV-1 expression in fibroblasts and coculture them with BCCs to investigate the effect of CAV‐1-deficient fibroblasts and the tumor microenvironment on breast cancer progression. Here, CAV1 is linked to neoplasm.